Table 3 Weighted agreement and score changes between RP GG and three biopsy schemes GG
From: A novel biopsy scheme for prostate cancer: targeted and regional systematic biopsy
|  | RP GG |  | Agreement | Weighted κ | Downgrade | No | Upgrade | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | Total | (%) | (95% CI) | Change | |||
TB GG |  |  |  |  | 43.3 | 0.48 (0.41–0.55) | 14.9% | 43.3% | 41.8% | ||
0 | 7 | 11 | 1 | 0 | 0 | 19 | Â | Â | 0 | 0 | 19 |
1 | 2 | 18 | 4 | 0 | 0 | 24 | Â | Â | 0 | 2 | 22 |
2 | 1 | 35 | 10 | 4 | 2 | 52 | Â | Â | 1 | 35 | 16 |
3 | 0 | 14 | 28 | 7 | 3 | 52 | Â | Â | 14 | 28 | 10 |
4 | 0 | 4 | 4 | 9 | 14 | 31 | Â | Â | 8 | 9 | 14 |
5 | 0 | 0 | 2 | 4 | 10 | 16 | Â | Â | 6 | 10 | 0 |
TrSB GG |  |  |  |  | 46.4 | 0.51 (0.43–0.58) | 16.0% | 46.4% | 37.6% | ||
0 | 2 | 1 | 0 | 0 | 0 | 3 | Â | Â | 0 | 0 | 3 |
1 | 5 | 22 | 3 | 0 | 0 | 30 | Â | Â | 0 | 5 | 25 |
2 | 3 | 41 | 15 | 4 | 1 | 64 | Â | Â | 3 | 41 | 20 |
3 | 0 | 14 | 25 | 7 | 5 | 51 | Â | Â | 14 | 25 | 12 |
4 | 0 | 4 | 3 | 9 | 13 | 29 | Â | Â | 7 | 9 | 13 |
5 | 0 | 0 | 3 | 4 | 10 | 17 | Â | Â | 7 | 10 | 0 |
STB GG |  |  |  |  | 45.9 | 0.51 (0.44–0.58) | 16.5% | 45.9% | 37.6% | ||
0 | 0 | 0 | 0 | 0 | 0 | 0 | Â | Â | 0 | 0 | 0 |
1 | 7 | 23 | 2 | 0 | 0 | 32 | Â | Â | 0 | 7 | 25 |
2 | 3 | 43 | 17 | 4 | 1 | 68 | Â | Â | 3 | 43 | 22 |
3 | 0 | 14 | 22 | 8 | 5 | 49 | Â | Â | 14 | 22 | 13 |
4 | 0 | 2 | 5 | 7 | 13 | 27 | Â | Â | 7 | 7 | 13 |
5 | 0 | 0 | 3 | 5 | 10 | 18 | Â | Â | 8 | 10 | 0 |